TFS Chemicals - Aspire
Pharma Focus America
Sino Biological - Cytokine

Curia and Carterra Join Forces for Biologics Symposium Advancing Biotechnology Research in the Pacific Northwest

Friday, May 10, 2024

Curia, a leading contract research, development, and manufacturing organization, and Carterra Inc., a global leader in label-free high-throughput antibody and small molecule drug discovery, have announced a partnership to host a high-throughput biologics symposium on May 31 at the Residence Inn at Marriott in Seattle, Washington.

Their collaboration aims to promote the growing biotech focus within the Pacific Northwest region of the U.S. and Canada. The symposium will gather scientific leaders from various levels of the biotech and pharma communities.

"We're excited to partner with Carterra in organizing this antibody discovery symposium, bringing together the Pacific Northwest biotech community to share the latest advances in antibody discovery," said Steve Lavezoli, Vice President of Biologics at Curia. "We're also looking forward to presenting our high-quality and accelerated antibody discovery workflows, which have led to antibodies from our platform technology entering clinical trials. We've successfully completed over 230 antibody discovery campaigns for the biotech sector."

The symposium will highlight Curia’s technology platform and services, focusing on the development of enhanced mouse systems for antibody generation and high-throughput single B cell screening. The integration of next-generation sequencing (NGS) and rapid recombinant production of purified monoclonal antibodies (mAbs) accelerates the identification of development candidate leads.

Carterra has been marketing its LSA® high-throughput biosensor since 2017 for the analysis and characterization of antibodies using Surface Plasmon Resonance (SPR). With the introduction of its LSAXT platform last year, Carterra now offers products capable of both small molecule analysis and antibody discovery. The LSA platform has been featured in numerous peer-reviewed papers, illustrating the trajectory of therapeutics entering clinical trials. Leading scientists in biopharma will share their insights into specific areas of drug discovery at the symposium, highlighting the impact of integrating HT-SPR technology, AI/ML, and other advanced technologies.

"We're thrilled to collaborate with Curia on our symposium. Carterra symposia serve as scientific forums that we host annually across the U.S. and Europe," remarked Chris M. Silva, Vice President of Marketing and Product at Carterra. "These events enable us to disseminate the latest technological advancements and significant data derived from the workflows of scientists utilizing Carterra’s label-free platforms. Venturing into the Pacific Northwest presents an opportunity to deepen awareness of our technology within pharma and biotechs in this region."



patheon - Mastering API production at every scaleWorld Vaccine Congress Europe 2024World Orphan Drug Congress 2024Future Labs Live USA 2024patheon - Revolutionizing PharmaHealthcare CNO SummitHealthcare CMO Summit